Clinical Trials and Regulatory Affairs

Clinical trials and regulatory affairs are critical components in the development and approval of vaccines, ensuring that they are both safe and effective for public use. Clinical trials follow a rigorous, multi-phase process to evaluate a vaccine's efficacy, safety, and optimal dosage, involving diverse participant groups to assess its impact across different populations. Each phase of the trial provides valuable data, from initial safety assessments in small groups to broader efficacy studies in larger populations. 

 

    Related Conference of Clinical Trials and Regulatory Affairs

    November 16-17, 2026

    7th International Conference on Vaccine Research

    Tokyo, Japan

    Clinical Trials and Regulatory Affairs Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in